SMARCB1 and schwannoma: Furthermore, many sporadically affected individuals that do not have either LZTR1 or SMARCB1 germline pathogenic variants but meet schwannomatosis criteria [21, 22], have mosaic NF2 with identical pathogenic variants in two separate schwannomas [2, 20, 23, 24].